Have a Topic Idea?

What would you like to see featured on MedConnect? Let us know.

Submit an Idea

Content with tag drug information update .

Examining Drug Trend: HIV

Drug price drove 2016 trend. Overall utilization for the top 10 therapeutic classes in 2016 decreased, while prices increased. To better understand 2016 trend, we will...

Drug Information Update- Mavyret (glecaprevir/pibrentasvir)

Mavyret (glecaprevir/pibrentasvir) New Drug Approval: On August 3, 2017 the FDA approved Mavyret for the treatment of adult patients with chronic...

Drug Information Update- Ocrevus (ocrelizumab)

Ocrevus (ocrelizumab) New Drug Approval: On March 28 th , 2017 the FDA approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of...

Drug Information Update- Kisqali (ribociclib)

Kisqali (ribociclib) New Drug Approval: On March 13 th , 2017 the FDA approved Kisqali (ribociclib) in combination with an aromatase inhibitor as initial...

Drug Information Update- Exondys 51 (eteplirsen)

New Drug Approval: On September 19 th , 2016 the FDA approved Exondys 51 (eteplirsen) for the treatment of Duchenne Muscular Dystrophy (DMD) in patients who...

Drug Information Update- Amjevita (adalimumab-atto)

New Drug Approval: On September 23 rd , 2016 the FDA approved Amjevita (adalimumab-atto), a biosimilar for Humira, for rheumatoid arthritis (RA), psoriatic...

Drug Information Update- Basaglar (insulin glargine)

New Drug Approval - Basaglar (insulin glargine) FDA Approval: In December 2015, the FDA approved Basaglar (insulin glargine), a long-acting human insulin...